Bill > AB1460

This bill addresses prescription drug pricing and aims to protect 340B community clinics from discriminatory practices by pharmaceutical manufacturers. Specifically, the bill prohibits drug manufacturers from imposing conditions that would restrict or interfere with a qualifying nonhospital 340B community clinic's ability to purchase or deliver drugs when using a specific pharmacy (including contract pharmacies) to dispense medications to eligible patients. The bill defines "discriminatory practices" as actions like limiting contract pharmacies, restricting medication discount eligibility, or adding arbitrary distance limitations. Qualifying clinics include licensed health centers, city or county clinics, rural health clinics, and other similar healthcare facilities that are 340B covered entities. The bill requires these clinics to annually conduct independent audits of contract pharmacies, report how 340B savings support patient care, and recertify their status with the federal Health Resources and Services Administration (HRSA). Additionally, the bill allows manufacturers to request deidentified claim information for investigating potential duplicate discounts or claim eligibility, but restricts the frequency and manner of such requests to protect patient privacy. The legislation aims to ensure fair access to discounted prescription drugs for community clinics and their patients.

Health and Social Services

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB1460